First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

October 19, 2018 9:23 pm Published by

Systemic lupus erythematosus (SLE) is a complex multisystemic
autoimmune disease resulting, oftentimes, in irreversible
damage, diminished quality of life and reduced life expectancy.1–3
Genetic and environmental factors play important roles
in its pathogenesis.4–8 Disease manifestations and severity vary
according to the patients’ racial/ethnic background and socioeconomic
status (SES).

Categorised in:

This post was written by admin